Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||FA2453 / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Blood pressure increased, Body temperature, Cough, Heart rate, Hyperhidrosis, Oxygen saturation, Pallor, Swelling of eyelid, Visual analogue scale, Blood pressure measurement
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Bronchial asthma
Diagnostic Lab Data: Test Date: 20210604; Test Name: Blood pressure; Result Unstructured Data: Test Result:164/66 mmHg; Test Date: 20210604; Test Name: Body temperature; Result Unstructured Data: Test Result:35.6 Centigrade; Comments: Before vaccination; Test Date: 20210604; Test Name: Pulse rate; Result Unstructured Data: Test Result:90; Comments: bpm; Test Date: 20210604; Test Name: Oxygen saturation; Result Unstructured Data: Test Result:97-98 %; Test Date: 20210604; Test Name: VAS; Result Unstructured Data: Test Result:decreased from 10 to 0; Comments: After intravenous treatment
CDC 'Split Type': JPPFIZER INC2021658879
Write-up: Cough; sweaty; poor complexion; Swelling of eyelid; Blood pressure 164/66 mmHg; This is a spontaneous report from a contactable physician received from the regulatory authority. Regulatory authority report number is v21111844. The patient was a 79-year-old female. Body temperature before vaccination was 35.6 degrees Centigrade. The patient had a medical history of asthma bronchial and has been taken Adoair 100 microgram. On 04Jun2021 at 14:20 (the day of vaccination), the patient received the first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot number FA2453, Expiration date 31Aug2021) via an unspecified route of administration as a single dose for COVID-19 immunization. Event onset date was reported as 04Jun2021 at 14:40. On 04Jun2021 (the day of vaccination), the outcome of the event was recovering. The course of the event was as follows: The patient experienced cough and sweaty. Blood pressure was 164/66 mmHg. Pulse rate was 90 bpm. Oxygen saturation was 97-98%. The patient was observed on Fowler''s position. The symptom was recovering, but the patient showed poor complexion. Solu-Medrol 40 mg + normal saline 100 ml was administered via intravenous drip. The symptom relieved. Swelling of eyelid also relieved. The VAS of the symptom decreased from 10 to 0. The patient went back home, then. The reporting physician classified the event as non-serious and assessed that the event was related to bnt162b2.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166